BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38701269)

  • 1. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
    Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
    Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
    J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
    Zou ZY; Shen B; Fan JG
    Inflamm Bowel Dis; 2019 Oct; 25(11):1764-1772. PubMed ID: 30918952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Zamani M; Alizadeh-Tabari S; Chitkara P; Singh S; Loomba R
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2789-2796. PubMed ID: 36871771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis.
    Zou A; Chen Y; Shi N; Ye Y
    Medicine (Baltimore); 2021 Oct; 100(40):e27368. PubMed ID: 34622837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
    Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Mantovani A; Nascimbeni F; Lonardo A; Zoppini G; Bonora E; Mantzoros CS; Targher G
    Thyroid; 2018 Oct; 28(10):1270-1284. PubMed ID: 30084737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaroenlapnopparat A; Charoenngam N; Ponvilawan B; Mariano M; Thongpiya J; Yingchoncharoen P
    Menopause; 2023 Mar; 30(3):348-354. PubMed ID: 36728528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis?
    Wei L; Ding HG
    Medicine (Baltimore); 2021 Aug; 100(31):e26706. PubMed ID: 34397807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
    Ning L; Liu R; Lou X; Du H; Chen W; Zhang F; Li S; Chen X; Xu G
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):735-742. PubMed ID: 30950907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk.
    Romero-Pérez D; Belinchón-Romero I; Bellot P; Francés R; Marco F; Ramos-Rincón JM
    Australas J Dermatol; 2019 Nov; 60(4):e304-e310. PubMed ID: 31236937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression.
    Orci LA; Sanduzzi-Zamparelli M; Caballol B; Sapena V; Colucci N; Torres F; Bruix J; Reig M; Toso C
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):283-292.e10. PubMed ID: 33965578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.